- •Preface
- •Acknowledgments
- •Contents
- •1.1 Introduction
- •1.2 Normal Embryology
- •1.3 Abnormalities of the Kidney
- •1.3.1 Renal Agenesis
- •1.3.2 Renal Hypoplasia
- •1.3.3 Supernumerary Kidneys
- •1.3.5 Polycystic Kidney Disease
- •1.3.6 Simple (Solitary) Renal Cyst
- •1.3.7 Renal Fusion and Renal Ectopia
- •1.3.8 Horseshoe Kidney
- •1.3.9 Crossed Fused Renal Ectopia
- •1.4 Abnormalities of the Ureter
- •1.5 Abnormalities of the Bladder
- •1.6 Abnormalities of the Penis and Urethra in Males
- •1.7 Abnormalities of Female External Genitalia
- •Further Reading
- •2.1 Introduction
- •2.2 Pathophysiology
- •2.3 Etiology of Hydronephrosis
- •2.5 Clinical Features
- •2.6 Investigations and Diagnosis
- •2.7 Treatment
- •2.8 Antenatal Hydronephrosis
- •Further Reading
- •3.1 Introduction
- •3.2 Embryology
- •3.3 Pathophysiology
- •3.4 Etiology of PUJ Obstruction
- •3.5 Clinical Features
- •3.6 Diagnosis and Investigations
- •3.7 Management of Newborns with PUJ Obstruction
- •3.8 Treatment
- •3.9 Post-operative Complications and Follow-Up
- •Further Reading
- •4: Renal Tumors in Children
- •4.1 Introduction
- •4.2 Wilms’ Tumor
- •4.2.1 Introduction
- •4.2.2 Etiology
- •4.2.3 Histopathology
- •4.2.4 Nephroblastomatosis
- •4.2.5 Clinical Features
- •4.2.6 Risk Factors for Wilms’ Tumor
- •4.2.7 Staging of Wilms Tumor
- •4.2.8 Investigations
- •4.2.9 Prognosis and Complications of Wilms Tumor
- •4.2.10 Surgical Considerations
- •4.2.11 Surgical Complications
- •4.2.12 Prognosis and Outcome
- •4.2.13 Extrarenal Wilms’ Tumors
- •4.3 Mesoblastic Nephroma
- •4.3.1 Introduction
- •4.3.3 Epidemiology
- •4.3.5 Clinical Features
- •4.3.6 Investigations
- •4.3.7 Treatment and Prognosis
- •4.4 Clear Cell Sarcoma of the Kidney (CCSK)
- •4.4.1 Introduction
- •4.4.2 Pathophysiology
- •4.4.3 Clinical Features
- •4.4.4 Investigations
- •4.4.5 Histopathology
- •4.4.6 Treatment
- •4.4.7 Prognosis
- •4.5 Malignant Rhabdoid Tumor of the Kidney
- •4.5.1 Introduction
- •4.5.2 Etiology and Pathophysiology
- •4.5.3 Histologic Findings
- •4.5.4 Clinical Features
- •4.5.5 Investigations and Diagnosis
- •4.5.6 Treatment and Outcome
- •4.5.7 Mortality/Morbidity
- •4.6 Renal Cell Carcinoma in Children
- •4.6.1 Introduction
- •4.6.2 Histopathology
- •4.6.4 Staging
- •4.6.5 Clinical Features
- •4.6.6 Investigations
- •4.6.7 Management
- •4.6.8 Prognosis
- •4.7 Angiomyolipoma of the Kidney
- •4.7.1 Introduction
- •4.7.2 Histopathology
- •4.7.4 Clinical Features
- •4.7.5 Investigations
- •4.7.6 Treatment and Prognosis
- •4.8 Renal Lymphoma
- •4.8.1 Introduction
- •4.8.2 Etiology and Pathogenesis
- •4.8.3 Diagnosis
- •4.8.4 Clinical Features
- •4.8.5 Treatment and Prognosis
- •4.9 Ossifying Renal Tumor of Infancy
- •4.10 Metanephric Adenoma
- •4.10.1 Introduction
- •4.10.2 Histopathology
- •4.10.3 Diagnosis
- •4.10.4 Clinical Features
- •4.10.5 Treatment
- •4.11 Multilocular Cystic Renal Tumor
- •Further Reading
- •Wilms’ Tumor
- •Mesoblastic Nephroma
- •Renal Cell Carcinoma in Children
- •Angiomyolipoma of the Kidney
- •Renal Lymphoma
- •Ossifying Renal Tumor of Infancy
- •Metanephric Adenoma
- •Multilocular Cystic Renal Tumor
- •5.1 Introduction
- •5.2 Embryology
- •5.4 Histologic Findings
- •5.7 Associated Anomalies
- •5.8 Clinical Features
- •5.9 Investigations
- •5.10 Treatment
- •Further Reading
- •6: Congenital Ureteral Anomalies
- •6.1 Etiology
- •6.2 Clinical Features
- •6.3 Investigations and Diagnosis
- •6.4 Duplex (Duplicated) System
- •6.4.1 Introduction
- •6.4.3 Clinical Features
- •6.4.4 Investigations
- •6.4.5 Treatment and Prognosis
- •6.5 Ectopic Ureter
- •6.5.1 Introduction
- •6.5.3 Clinical Features
- •6.5.4 Diagnosis
- •6.5.5 Surgical Treatment
- •6.6 Ureterocele
- •6.6.1 Introduction
- •6.6.3 Clinical Features
- •6.6.4 Investigations and Diagnosis
- •6.6.5 Treatment
- •6.6.5.1 Surgical Interventions
- •6.8 Mega Ureter
- •Further Reading
- •7: Congenital Megaureter
- •7.1 Introduction
- •7.3 Etiology and Pathophysiology
- •7.4 Clinical Presentation
- •7.5 Investigations and Diagnosis
- •7.6 Treatment and Prognosis
- •7.7 Complications
- •Further Reading
- •8.1 Introduction
- •8.2 Pathophysiology
- •8.4 Etiology of VUR
- •8.5 Clinical Features
- •8.6 Investigations
- •8.7 Management
- •8.7.1 Medical Treatment of VUR
- •8.7.2 Antibiotics Used for Prophylaxis
- •8.7.3 Anticholinergics
- •8.7.4 Surveillance
- •8.8 Surgical Therapy of VUR
- •8.8.1 Indications for Surgical Interventions
- •8.8.2 Indications for Surgical Interventions Based on Age at Diagnosis and the Presence or Absence of Renal Lesions
- •8.8.3 Endoscopic Injection
- •8.8.4 Surgical Management
- •8.9 Mortality/Morbidity
- •Further Reading
- •9: Pediatric Urolithiasis
- •9.1 Introduction
- •9.2 Etiology
- •9.4 Clinical Features
- •9.5 Investigations
- •9.6 Complications of Urolithiasis
- •9.7 Management
- •Further Reading
- •10.1 Introduction
- •10.2 Embryology of Persistent Müllerian Duct Syndrome
- •10.3 Etiology and Inheritance of PMDS
- •10.5 Clinical Features
- •10.6 Treatment
- •10.7 Prognosis
- •Further Reading
- •11.1 Introduction
- •11.2 Physiology and Bladder Function
- •11.2.1 Micturition
- •11.3 Pathophysiological Changes of NBSD
- •11.4 Etiology and Clinical Features
- •11.5 Investigations and Diagnosis
- •11.7 Management
- •11.8 Clean Intermittent Catheterization
- •11.9 Anticholinergics
- •11.10 Botulinum Toxin Type A
- •11.11 Tricyclic Antidepressant Drugs
- •11.12 Surgical Management
- •Further Reading
- •12.1 Introduction
- •12.2 Etiology
- •12.3 Pathophysiology
- •12.4 Clinical Features
- •12.5 Investigations and Diagnosis
- •12.6 Management
- •Further Reading
- •13.1 Introduction
- •13.2 Embryology
- •13.3 Epispadias
- •13.3.1 Introduction
- •13.3.2 Etiology
- •13.3.4 Treatment
- •13.3.6 Female Epispadias
- •13.3.7 Surgical Repair of Female Epispadias
- •13.3.8 Prognosis
- •13.4 Bladder Exstrophy
- •13.4.1 Introduction
- •13.4.2 Associated Anomalies
- •13.4.3 Principles of Surgical Management of Bladder Exstrophy
- •13.4.4 Evaluation and Management
- •13.5 Cloacal Exstrophy
- •13.5.1 Introduction
- •13.5.2 Skeletal Changes in Cloacal Exstrophy
- •13.5.3 Etiology and Pathogenesis
- •13.5.4 Prenatal Diagnosis
- •13.5.5 Associated Anomalies
- •13.5.8 Surgical Reconstruction
- •13.5.9 Management of Urinary Incontinence
- •13.5.10 Prognosis
- •13.5.11 Complications
- •Further Reading
- •14.1 Introduction
- •14.2 Etiology
- •14.3 Clinical Features
- •14.4 Associated Anomalies
- •14.5 Diagnosis
- •14.6 Treatment and Prognosis
- •Further Reading
- •15: Cloacal Anomalies
- •15.1 Introduction
- •15.2 Associated Anomalies
- •15.4 Clinical Features
- •15.5 Investigations
- •Further Reading
- •16: Urachal Remnants
- •16.1 Introduction
- •16.2 Embryology
- •16.4 Clinical Features
- •16.5 Tumors and Urachal Remnants
- •16.6 Management
- •Further Reading
- •17: Inguinal Hernias and Hydroceles
- •17.1 Introduction
- •17.2 Inguinal Hernia
- •17.2.1 Incidence
- •17.2.2 Etiology
- •17.2.3 Clinical Features
- •17.2.4 Variants of Hernia
- •17.2.6 Treatment
- •17.2.7 Complications of Inguinal Herniotomy
- •17.3 Hydrocele
- •17.3.1 Embryology
- •17.3.3 Treatment
- •Further Reading
- •18: Cloacal Exstrophy
- •18.1 Introduction
- •18.2 Etiology and Pathogenesis
- •18.3 Associated Anomalies
- •18.4 Clinical Features and Management
- •Further Reading
- •19: Posterior Urethral Valve
- •19.1 Introduction
- •19.2 Embryology
- •19.3 Pathophysiology
- •19.5 Clinical Features
- •19.6 Investigations and Diagnosis
- •19.7 Management
- •19.8 Medications Used in Patients with PUV
- •19.10 Long-Term Outcomes
- •19.10.3 Bladder Dysfunction
- •19.10.4 Renal Transplantation
- •19.10.5 Fertility
- •Further Reading
- •20.1 Introduction
- •20.2 Embryology
- •20.4 Clinical Features
- •20.5 Investigations
- •20.6 Treatment
- •20.7 The Müllerian Duct Cyst
- •Further Reading
- •21: Hypospadias
- •21.1 Introduction
- •21.2 Effects of Hypospadias
- •21.3 Embryology
- •21.4 Etiology of Hypospadias
- •21.5 Associated Anomalies
- •21.7 Clinical Features of Hypospadias
- •21.8 Treatment
- •21.9 Urinary Diversion
- •21.10 Postoperative Complications
- •Further Reading
- •22: Male Circumcision
- •22.1 Introduction
- •22.2 Anatomy and Pathophysiology
- •22.3 History of Circumcision
- •22.4 Pain Management
- •22.5 Indications for Circumcision
- •22.6 Contraindications to Circumcision
- •22.7 Surgical Procedure
- •22.8 Complications of Circumcision
- •Further Reading
- •23: Priapism in Children
- •23.1 Introduction
- •23.2 Pathophysiology
- •23.3 Etiology
- •23.5 Clinical Features
- •23.6 Investigations
- •23.7 Management
- •23.8 Prognosis
- •23.9 Priapism and Sickle Cell Disease
- •23.9.1 Introduction
- •23.9.2 Epidemiology
- •23.9.4 Pathophysiology
- •23.9.5 Clinical Features
- •23.9.6 Treatment
- •23.9.7 Prevention of Stuttering Priapism
- •23.9.8 Complications of Priapism and Prognosis
- •Further Reading
- •24.1 Introduction
- •24.2 Embryology and Normal Testicular Development and Descent
- •24.4 Causes of Undescended Testes and Risk Factors
- •24.5 Histopathology
- •24.7 Clinical Features and Diagnosis
- •24.8 Treatment
- •24.8.1 Success of Surgical Treatment
- •24.9 Complications of Orchidopexy
- •24.10 Infertility and Undescended Testes
- •24.11 Undescended Testes and the Risk of Cancer
- •Further Reading
- •25: Varicocele
- •25.1 Introduction
- •25.2 Etiology
- •25.3 Pathophysiology
- •25.4 Grading of Varicoceles
- •25.5 Clinical Features
- •25.6 Diagnosis
- •25.7 Treatment
- •25.8 Postoperative Complications
- •25.9 Prognosis
- •Further Reading
- •26.1 Introduction
- •26.2 Etiology and Risk Factors
- •26.3 Diagnosis
- •26.4 Intermittent Testicular Torsion
- •26.6 Effects of Testicular Torsion
- •26.7 Clinical Features
- •26.8 Treatment
- •26.9.1 Introduction
- •26.9.2 Etiology of Extravaginal Torsion
- •26.9.3 Clinical Features
- •26.9.4 Treatment
- •26.10 Torsion of the Testicular or Epididymal Appendage
- •26.10.1 Introduction
- •26.10.2 Embryology
- •26.10.3 Clinical Features
- •26.10.4 Investigations and Treatment
- •Further Reading
- •27: Testicular Tumors in Children
- •27.1 Introduction
- •27.4 Etiology of Testicular Tumors
- •27.5 Clinical Features
- •27.6 Staging
- •27.6.1 Regional Lymph Node Staging
- •27.7 Investigations
- •27.8 Treatment
- •27.9 Yolk Sac Tumor
- •27.10 Teratoma
- •27.11 Mixed Germ Cell Tumor
- •27.12 Stromal Tumors
- •27.13 Simple Testicular Cyst
- •27.14 Epidermoid Cysts
- •27.15 Testicular Microlithiasis (TM)
- •27.16 Gonadoblastoma
- •27.17 Cystic Dysplasia of the Testes
- •27.18 Leukemia and Lymphoma
- •27.19 Paratesticular Rhabdomyosarcoma
- •27.20 Prognosis and Outcome
- •Further Reading
- •28: Splenogonadal Fusion
- •28.1 Introduction
- •28.2 Etiology
- •28.4 Associated Anomalies
- •28.5 Clinical Features
- •28.6 Investigations
- •28.7 Treatment
- •Further Reading
- •29: Acute Scrotum
- •29.1 Introduction
- •29.2 Torsion of Testes
- •29.2.1 Introduction
- •29.2.3 Etiology
- •29.2.4 Clinical Features
- •29.2.5 Effects of Torsion of Testes
- •29.2.6 Investigations
- •29.2.7 Treatment
- •29.3 Torsion of the Testicular or Epididymal Appendage
- •29.3.1 Introduction
- •29.3.2 Embryology
- •29.3.3 Clinical Features
- •29.3.4 Investigations and Treatment
- •29.4.1 Introduction
- •29.4.2 Etiology
- •29.4.3 Clinical Features
- •29.4.4 Investigations and Treatment
- •29.5 Idiopathic Scrotal Edema
- •29.6 Testicular Trauma
- •29.7 Other Causes of Acute Scrotum
- •29.8 Splenogonadal Fusion
- •Further Reading
- •30.1 Introduction
- •30.2 Imperforate Hymen
- •30.3 Vaginal Atresia
- •30.5 Associated Anomalies
- •30.6 Embryology
- •30.7 Clinical Features
- •30.8 Investigations
- •30.9 Management
- •Further Reading
- •31: Disorders of Sexual Development
- •31.1 Introduction
- •31.2 Embryology
- •31.3 Sexual and Gonadal Differentiation
- •31.5 Evaluation of a Newborn with DSD
- •31.6 Diagnosis and Investigations
- •31.7 Management of Patients with DSD
- •31.8 Surgical Corrections of DSD
- •31.9 Congenital Adrenal Hyperplasia (CAH)
- •31.10 Androgen Insensitivity Syndrome (Testicular Feminization Syndrome)
- •31.13 Gonadal Dysgenesis
- •31.15 Ovotestis Disorders of Sexual Development
- •31.16 Other Rare Disorders of Sexual Development
- •Further Reading
- •Index
Cloacal Exstrophy |
18 |
|
18.1Introduction
•Cloacal exstrophy is an extremely rare and major birth defect representing the severe end of the spectrum of the exstrophy-epispadias complex (Fig. 18.1).
•It is also called vessico-intestinal fissure.
•The exact incidence of cloacal exstrophy is not known but the estimated prevalence ranges from 1 in 50,000 to 250,000 live births.
•It is more common in males than females (a male-female ratio of 2:1).
•Cloacal exstrophy, is also called the OEIS Complex:
–O: Omphalocele
–E: Exstrophy of the cloaca
–I: Imperforate Anus
–S: Spinal Defects
•Clinically, patients with cloacal exstrophy present at birth and it is characterized by the followings spectrum of anomalies (Figs. 18.2, 18.3, 18.4, 18.5, and 18.6):
–Two exstrophied hemibladders
–These are separated by a foreshortened hindgut or cecum
–The hindgut is often blind-ending resulting in an imperforate anus.
–This extrophied ileo-cecal region presents between the two hemi bladders (the “elephant trunk” appearance).
–Omphalocele
–The associated omphalocele may be major or minor and sometimes no associated omphalocele.
–Malrotation
–The symphysis pubis is widely separated
–The pelvis is often asymmetrically shaped
–The genitalia (ambiguous genitalia):
•In males, the penis is divided into two halves usually located separately on either side of the bladder plates with the adjacent scrotal halves.
•In females, the clitoris is divided into two haves usually located separately on either side of the bladder plates with the adjacent part.
•Duplication of the vagina and uterus
•Vaginal agenesis
18.2Etiology and Pathogenesis
•The exact etiology of cloacal exstrophy is not known.
•Several theories have been proposed to explain the pathogenesis of cloacal exstrophy but none of them can fully explain the spectrum of anomalies seen in cloacal exstrophy.
•The most accepted theory is that cloacal exstrophy results from premature rupture of the cloacal membrane prior to caudal migration of the urorectal septum, and failure of fusion of the genital tubercles.
© Springer International Publishing Switzerland 2017 |
415 |
A.H. Al-Salem, An Illustrated Guide to Pediatric Urology, DOI 10.1007/978-3-319-44182-5_18 |
|
416 |
|
|
|
18 Cloacal Exstrophy |
||
|
|
|
|
|
|
|
Fig. 18.1 Clinical photo- |
|
|
|
|
|
|
graph showing the compo- |
|
|
OMPHALOCELE |
|
|
|
nents of the cloacal |
|
|
|
|
|
|
|
|
|
|
|
|
|
exstrophy |
HEMIBLADDER |
|
|
|
|
|
|
|
HEMIBLADDER |
|
|||
|
|
|
|
|
||
|
|
|
ILEOCECAL REGION
Figs. 18.2 and |
|
||
OMPHALOCEL |
|||
18.3 |
Clinical photographs |
||
|
|||
|
showing two patients with |
|
HEMIBLADDER |
|
HEMIBLADDER |
|
cloacal exstrophy. Note the |
|
|
|
|
|
difference in the size of |
|
|
|
|
|
omphalocele and also the |
|
|
|
|
|
extent of the exstrophied |
|
|
|
|
|
ileo-cecal region |
|
|
|
|
|
|
|
|
|
|
|
|
ILEOCECAL REGION |
|
|
|
|
|
|
|
|
|
|
OMPHALOCELE
HEMIBLADDER
HEMIBLADDER
ILEOCECAL REGION
•Embryo logically:
–The urorectal septum divides the cloaca into an anterior urogenital sinus and a posterior anorectal canal.
–This occurs around the fourth week of intrauterine life and simultaneously, the cloacal membrane is invaded by lateral mesodermal folds.
–It is postulated that if this mesodermal invasion does not occur, the infraumbilical
cloacal membrane persists leading to poor lower abdominal wall development.
–The cloacal membrane eventually ruptures but if this happens prior to the descent of the urorectal septum which happens at 6–8 weeks of gestation, then cloacal exstrophy results.
–Cloacal exstrophy develops as a result of:
•Failure of the urorectal septum to develop and divides the urogenital sinus anteriorly from the rectum posteriorly.
18.3 Associated Anomalies |
417 |
|
|
Figs. 18.4 and
18.5 Clinical photographs showing cloacal exstrophy in two patients. Note the absence of omphalocele in the first one and associated anorectal agenesis in the second one
NO OMPHALOCELE
OPENED
URINARY
BLADDER
PROLAPSED
ILEOCECAL
REGION
OPENED
URINARY
BLADDER
HEMIBLADDER
HEMIBLADDER
ANORECTAL
AGENESIS
Fig. 18.6 A clinical photograph showing cloacal exstrophy. Note the associated anorectal agenesis
•Failure of the mesoderm forming the infraumbilical abdominal wall to proliferate and form the lower abdominal wall
•Failure of the genital tubercle to develop.
•Failure of these events to occur results in exstrophy of both bladder and intestine.
–Classically, cloacal exstrophy is made up of omphalocele, exstrophied ileocecal region of bowel, exstrophied hemi bladders
PROLAPSED
ILEOCECAL
REGION
ANORECTAL
AGENESIS
each with its ipsilateral ureter, and anorectal agenesis.
–The pubic bones are widely separated, and spinal dysraphism is common in these patients.
18.3Associated Anomalies
•Cloacal exstrophy is commonly associated with other anomalies including cardiovascular, and central nervous system anomalies.
•Omphalocele is present in 70–90 % of patients with cloacal exstrophy.
•Spinal and skeletal anomalies (46 %). These include (Figs. 18.7 and 18.8):
–Hemivertebra
–Myelomeningocele
–Clubfoot deformities
–Absence of feet
–Tibial/fibular deformities
–Hip dislocation
418 |
18 Cloacal Exstrophy |
|
|
Fig. 18.7 Clinical photograph of a newborn with cloacal exstrophy. Note also the associated bilateral tallipes equinovarus
•Upper urinary tract anomalies (42 %).
–Pelvic kidney
–Horseshoe kidney
–Hypoplastic kidney
–Solitary kidney
•Malrotation (30 %)
–Urological malformations:
•Ureteropelvic junction obstruction
•Ectopic pelvic kidney
•Horseshoe kidney
•Hypoplastic kidney or renal agenesis
•Megaureter
•Ureteral ectopy and ureterocele
•Lower extremity anomalies (30 %)
•Double appendix (30 %)
•Absent appendix (21 %)
•Short bowel syndrome (19–46 %)
•Gastrointestinal duplications
•Small bowel atresia (5 %)
•Abdominal wall musculature deficiency (1 %)
Fig. 18.8 Abdominal x-ray showing widened pubic bone and abnormal asymmetrical pelvis
–Sacralization of L5
–Congenital scoliosis
–Sacral agenesis
–Interpedicular widening
18.4Clinical Features and Management
•Cloacal exstrophy is a very rare and complex anomaly of the urogenital tract and intestinal tract resulting in exstrophy of both bowel and bladder (Fig. 18.9).
•Commonly in cloacal exstrophy, the exstrophied bowel is the ileo-cecal region with little or no large bowel distally, but there are cases where there is colonic exstrophy with sufficient large bowel length. A small colon usually ends blindly in the pelvis, and the terminal ileum often prolapses out of the exposed cecum (Figs. 18.10 and 18.11).
•The presence of enough large bowel is advantageous from the reconstruction point of view.
•The extrophied ileo-cecal region and in the presence of short large bowel should be preserved for reconstruction of the anorectal malformation.
•Every effort should be made to preserve all large intestines because not only it can be used for bladder augmentation which is necessary in the majority of these patients to increase the bladder compliance, but also for reconstruction of the anorectal malformation and vaginal reconstruction in those who have vaginal
18.4 Clinical Features and Management |
419 |
|
|
Fig. 18.9 A clinical photograph showing cloacal exstrophy. Note the prolapsing terminal ileum out of the exposed cecum
HEMIBLADDER
HEMIBLADDER
PROLAPSED
TERMINAL ILEUM
Figs. 18.10 and 18.11 A clinical photograph showing cloacal exstrophy. Note the omphalocele, the urinary bladder into two halves and the prolapsed ileo-cecal
region with the terminal ileum open with meconium passing from it. Note the large size of the associated omphalocele
agenesis or those undergoing gender reassignment (Figs. 18.12, 18.13, 18.14, and 18.15).
•Add to this the valuable absorptive function of the large bowel.
•Augmentation of the urinary bladder may be performed using the hindgut if enough length is available, ileum, or part of the stomach. In the absence of large intestine, both small bowel and stomach can be used for bladder augmentation but gastrocytoplasty was shown to be superior.
•Gender assignment is one of the difficult tasks in the management of newborns with cloacal exstrophy.
•Genetic females should not raise a problem as they will be raised as females.
•In genetic males with cloacal exstrophy, the phallic structures are usually small and completely bifid with insufficient phallic tissue to reconstruct an adequate penis.
•There is now general consensus that genetic males with insufficient phallus be gender reassigned as phenotypic females, and to minimize testosterone imprinting on the nervous system, this should be done in the immediate newborn period with early orchidectomy.
•Males with adequate bilateral or unilateral phallic structures should however, be raised as males.
•In the classic repair of cloacal exstrophy in males an epispadias is created initially after
420 |
18 Cloacal Exstrophy |
|
|
Figs. 18.12 and 18.13 Clinical photographs showing cloacal extrophy. Note the prolapsed bowel and also the abdominal wall defect but no clear omphlocele. The bladder defect is covered by the large prolapsing bowel
DIVIDED
ILEUM
HEMIBLADDER
URETERIC
CATHETER
HEMIBLADDER
URETERIC
CATHETER
Fig. 18.14 A clinical intraoperative photograph of cloacal exstrophy being repaired. Note the two ureteric catheters inserted and the mobilized urinary bladder. Note also the divided ileum to form an ileostomy. Part of the bowel is left in the posterior wall of the urinary bladder for bladder augmentation
urinary bladder closure. This is repaired later and will require the use of long acting testosterone to increase the size and length of the penis.
•The management of newborns with cloacal exstrophy has progressed over the years, and now a very reasonable outcome is expected in most cases.
ILEOSTOMY
HEMIBLADDER
URETERIC
CATHETER
Fig. 18.15 Clinical intraoperative photograph showing a diverting ileostomy and ureteric catheters prior to closure of the urinary bladder
•This, however, requires a team approach including:
–Neonatologists
–Pediatric surgeons
–Pediatric urologist
–Neurosurgeons
–Pediatric orthopedic surgeons
–Geneticists
–Social workers
–Stomatherapist
•Although there are general guidelines in managing newborns with cloacal exstrophy, after thor-